We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DENTSPLY SIRONA Inc. (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #4 (Sell) but that could change following its second quarter 2018 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.) We have highlighted some of the key details from the just-released announcement below:
Earnings: DENTSPLY reported adjusted earnings of 60 cents per share, which came above the Zacks Consensus Estimate by a penny and was higher than earnings of 65 cents in the year-ago quarter.
Revenues: DENTSPLY’s net sales increased to $1.04 billion from $992.7 million in the year-ago period. Net sales increased 5% on a year over year basis.
This also came above the Zacks Consensus Estimate of $1.03 billion.
Net sales, excluding precious metals, increased 5.1% on a year over year basis to $1.03 billion.
Important Details: In the second quarter, DENTSPLY recorded a goodwill and intangible impairment charge of $1.27 billion. Of this charge, almost $1.20 billion was in the Technologies and Equipment segment.
The Consumable Segment suffered charges worth $69 million for impairment.
Narrowed Guidance:The company narrowed its adjusted EPS guidance for 2018 to the range of $2.00 to $2.15 per share. Earlier, the company projected adjusted EPS in a range of $2.55 to $2.65.
Share Price:Following the earnings release, share prices plunged 18.5% in the pre-market trading session.
Check back later for our full write up on this DENTSPLY earnings report later!
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
DENTSPLY (XRAY) Q2 Earnings Beat Estimates, Sales Rise Y/Y
DENTSPLY SIRONA Inc. (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #4 (Sell) but that could change following its second quarter 2018 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.) We have highlighted some of the key details from the just-released announcement below:
Earnings: DENTSPLY reported adjusted earnings of 60 cents per share, which came above the Zacks Consensus Estimate by a penny and was higher than earnings of 65 cents in the year-ago quarter.
Revenues: DENTSPLY’s net sales increased to $1.04 billion from $992.7 million in the year-ago period. Net sales increased 5% on a year over year basis.
This also came above the Zacks Consensus Estimate of $1.03 billion.
Net sales, excluding precious metals, increased 5.1% on a year over year basis to $1.03 billion.
DENTSPLY SIRONA Inc. Price and EPS Surprise
DENTSPLY SIRONA Inc. Price and EPS Surprise | DENTSPLY SIRONA Inc. Quote
Important Details: In the second quarter, DENTSPLY recorded a goodwill and intangible impairment charge of $1.27 billion. Of this charge, almost $1.20 billion was in the Technologies and Equipment segment.
The Consumable Segment suffered charges worth $69 million for impairment.
Narrowed Guidance:The company narrowed its adjusted EPS guidance for 2018 to the range of $2.00 to $2.15 per share. Earlier, the company projected adjusted EPS in a range of $2.55 to $2.65.
Share Price:Following the earnings release, share prices plunged 18.5% in the pre-market trading session.
Check back later for our full write up on this DENTSPLY earnings report later!
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>